Twist Bioscience Corp (TWST) Stock Price, Quote & News

Company Profile

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing,...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 800 719 0671

Website: www.twistbioscience.com

Address:

681 Gateway Boulevard, South San Francisco, United States

Minkhadka90 Aug. 1 at 8:05 PM

$TWST

0 · Reply

RHINOStocks Jul. 28 at 2:34 PM

$TWST Watching closely. Potentiel breakout. Would love to see a pullback to the 0.5 fib lvl before that breakout to add. 1st price target : 51.49

0 · Reply

Thelonius_Stonk Jul. 21 at 2:26 PM

$TWST happy to know this thing still trades like garbage

0 · Reply

RemitTekram Jul. 10 at 1:04 AM

$TWST 😀

0 · Reply

Shawzzzzzz Jul. 7 at 2:28 PM

$TWST all selling low volume this morning.

0 · Reply

BeanSupreme Jul. 3 at 2:35 PM

$TWST Cathy Wood buying this was a death sentence.

1 · Reply

Estimize Jul. 2 at 9:00 PM

Wall St is expecting -0.52 EPS for $TWST Q3 [Reporting 08/01 BMO] http://www.estimize.com/intro/twst?chart=historical&metric_name=eps&utm_c

0 · Reply

JimBob2 Jun. 30 at 1:31 AM

$TWST bullish

0 · Reply

bettingonbiotech Jun. 25 at 8:41 PM

$TWST what was that jump about

2 · Reply

Shawzzzzzz Jun. 25 at 8:04 PM

$TWST 500,000 shares traded in the last 37 minutes of trading

0 · Reply

Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model

Jul 24, 2025, 8:00 AM EDT - 10 days ago

Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Jul 15, 2025, 4:02 PM EDT - 18 days ago

Twist Bioscience: Still Not There Yet

Jul 14, 2025, 8:00 AM EDT - 20 days ago

Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025

Jul 7, 2025, 8:00 AM EDT - 27 days ago

Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format

May 22, 2025, 8:00 AM EDT - 2 months ago

Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions

May 15, 2025, 8:00 AM EDT - 2 months ago

Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference

May 8, 2025, 8:00 AM EDT - 3 months ago

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

DNA

May 7, 2025, 2:18 AM EDT - 3 months ago

Twist Bioscience: Expansion Efforts Continue To Face Challenges

May 5, 2025, 11:41 AM EDT - 3 months ago

Twist Bioscience Corporation (TWST) Q2 2025 Earnings Call Transcript

May 5, 2025, 7:15 AM EDT - 3 months ago

Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results

May 5, 2025, 7:10 AM EDT - 3 months ago

Twist Bioscience Spins Out DNA Data Storage as Independent Company

May 1, 2025, 12:05 PM EDT - 3 months ago

Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers

Apr 24, 2025, 8:00 AM EDT - 3 months ago

Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System

Mar 31, 2025, 8:00 AM EDT - 4 months ago

Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics

Mar 11, 2025, 7:30 AM EDT - 5 months ago

Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost

Feb 25, 2025, 8:00 AM EST - 5 months ago

Twist Bioscience to Present at Upcoming Investor Conferences

Feb 19, 2025, 8:00 AM EST - 5 months ago

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Feb 5, 2025, 11:30 PM EST - 6 months ago

Twist Bioscience: Valuation Is Weighing On The Stock

Feb 3, 2025, 10:55 AM EST - 6 months ago

Twist Bioscience Corporation (TWST) Q1 2025 Earnings Call Transcript

Feb 3, 2025, 7:15 AM EST - 6 months ago

Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results

Jan 23, 2025, 10:35 AM EST - 6 months ago

Gene Synthesis Market Size to Surpass USD 9.54 Billion by 2033 | Straits Research

Jan 22, 2025, 8:00 AM EST - 6 months ago

Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025

Dec 19, 2024, 8:00 AM EST - 8 months ago

Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference

Nov 29, 2024, 9:55 AM EST - 8 months ago

Twist Bioscience: Path To Profitability Beginning To Take Shape

Nov 18, 2024, 3:16 PM EST - 9 months ago

Twist Bioscience: A Post-Earnings Assessment

Nov 18, 2024, 12:17 PM EST - 9 months ago

Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps

Nov 18, 2024, 11:31 AM EST - 9 months ago

Twist Bioscience Corporation (TWST) Q4 2024 Earnings Call Transcript

Nov 18, 2024, 7:15 AM EST - 9 months ago

Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results

Nov 14, 2024, 8:00 AM EST - 9 months ago

Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference

Nov 8, 2024, 5:14 AM EST - 9 months ago

Twist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy'

Oct 30, 2024, 8:00 AM EDT - 9 months ago

Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics

Oct 24, 2024, 8:00 AM EDT - 10 months ago

Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024

Oct 22, 2024, 8:00 AM EDT - 10 months ago

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

XOMA

Oct 15, 2024, 8:00 AM EDT - 10 months ago

Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer

Sep 12, 2024, 8:00 AM EDT - 11 months ago

Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance

Sep 9, 2024, 8:00 AM EDT - 11 months ago

Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels

Aug 27, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience to Present at Baird Global Healthcare Conference 2024

Aug 8, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb

Aug 5, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis

Aug 4, 2024, 8:50 AM EDT - 1 year ago

Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade)

Aug 2, 2024, 2:37 PM EDT - 1 year ago

Twist Bioscience Corporation (TWST) Q3 2024 Earnings Call Transcript

Aug 2, 2024, 10:01 AM EDT - 1 year ago

Twist Bioscience Beats Q3 Earnings Forecast, Plans To Achieve 50% Gross Margin By Fiscal Year 2025

Aug 2, 2024, 7:30 AM EDT - 1 year ago

Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results

Jul 26, 2024, 6:39 AM EDT - 1 year ago

Twist Bioscience: Growing Customer Base And Technology Platform Make Me Like This Stock

Jul 18, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Announces Clinical Progression of Pure Biologics' Antibody Candidate Discovered Using Twist's Antibody Libraries

Jul 11, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024

Jul 10, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies

Jul 9, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A

Jun 6, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor

Minkhadka90 Aug. 1 at 8:05 PM

$TWST

0 · Reply

RHINOStocks Jul. 28 at 2:34 PM

$TWST Watching closely. Potentiel breakout. Would love to see a pullback to the 0.5 fib lvl before that breakout to add. 1st price target : 51.49

0 · Reply

Thelonius_Stonk Jul. 21 at 2:26 PM

$TWST happy to know this thing still trades like garbage

0 · Reply

RemitTekram Jul. 10 at 1:04 AM

$TWST 😀

0 · Reply

Shawzzzzzz Jul. 7 at 2:28 PM

$TWST all selling low volume this morning.

0 · Reply

BeanSupreme Jul. 3 at 2:35 PM

$TWST Cathy Wood buying this was a death sentence.

1 · Reply

Estimize Jul. 2 at 9:00 PM

Wall St is expecting -0.52 EPS for $TWST Q3 [Reporting 08/01 BMO] http://www.estimize.com/intro/twst?chart=historical&metric_name=eps&utm_c

0 · Reply

JimBob2 Jun. 30 at 1:31 AM

$TWST bullish

0 · Reply

bettingonbiotech Jun. 25 at 8:41 PM

$TWST what was that jump about

2 · Reply

Shawzzzzzz Jun. 25 at 8:04 PM

$TWST 500,000 shares traded in the last 37 minutes of trading

0 · Reply

Shawzzzzzz Jun. 25 at 7:08 PM

$TWST BIG jump in the past 10 mins

0 · Reply

Thelonius_Stonk Jun. 25 at 6:58 PM

$TWST dunt get it TWSTd

0 · Reply

Professor Jun. 23 at 10:26 PM

$ARKQ Monthly chart of Ark Autonomous Tech & Robotics looks PRIMED. Ark is soon to become an arrow. Top 5 holdings: $TEM $CRSP $TWST $RXRX $NTA

0 · Reply

Thelonius_Stonk Jun. 19 at 10:11 AM

$TWST worth a look

1 · Reply

RemitTekram Jun. 18 at 3:28 PM

$TWST Still believe in this beauty. Haven't let go since the teens.

0 · Reply

KhalidsCapital Jun. 18 at 2:47 PM

GLMD is a ticking time bomb 💣 Trading under cash. $20+ book. No debt. GLP-1 catalysts loading. Tiny float. This could 5x out of nowhere. Chart’s ready. $CRTT $VPRO $TWST $OXBR

0 · Reply

cc10socr Jun. 11 at 5:11 PM

$TWST pick me up at 76.9

0 · Reply

StockHunter75 Jun. 11 at 2:03 PM

$TWST buy as much as you can afford.

0 · Reply

StockHunter75 Jun. 11 at 2:02 PM

$TWST Still Holding strong.

0 · Reply

StockHunter75 Jun. 10 at 2:48 PM

$TWST 40 plus in the short term.

0 · Reply

StockHunter75 Jun. 9 at 2:03 PM

$TWST Buying more

0 · Reply

Shawzzzzzz Jun. 3 at 3:36 PM

$TWST 30% CAGR

0 · Reply

Market Cap	2.02B
Revenue (ttm)	312.97M
Net Income (ttm)	-208.73M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-66.69%
Debt to Equity Ratio	0.03

Volume	1,382,800
Avg Vol	1,051,862
Day's Range	N/A - N/A
Shares Out	59.92M
Stochastic %K	27%
Beta	2.37
Analysts	Strong Sell
Price Target	$47.50